ArticleJournal of nanobiotechnology2021

Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples.

Jiajie Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.